Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467109) titled 'A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers' on March 9.
Study Type: Observational
Primary Sponsor: M.D. Anderson Cancer Center
Condition:
Intracranial Venous Blood
Brain Cancers
Liquid Biopsy
Evaluate the Safety
Intervention:
Diagnostic Test: blood sampling
Recruitment Status: Not recruiting
Date of First Enrollment: August 19, 2026
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07467109
Disclaimer: Curated by HT Syndication....